Skip to main content

Utility of Renal Replacement Therapy for Infants With Congenital Diaphragmatic Hernia Receiving Extracorporeal Life Support

In brief

Renal replacement therapy linked to 36% survival in infants on life support

In matched pairs of infants with congenital diaphragmatic hernia on extracorporeal life support, 36% of those receiving renal replacement therapy survived to discharge, compared with 57% without it. Treatment was also associated with longer support and more severe kidney injury, but likely marks clinical deterioration; the association with lower survival appeared only among infants who had repair while on support.

Journal
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies (Q1)
Published
19 November 2026
Study design
Retrospective cohort
Evidence level
Level 3, Low (CEBM 3b)
Authors
Daniel B Gehle, Pilar Anton-Martin, Nicolle M Burgwardt, Yigit S Guner, Tim Jancelewicz
PMID
43055550
DOI
10.1097/PCC.0000000000004121

Why clinicians should know about it

  • Picked for Pediatric Surgery (paper of the day, 21 November 2026): CDH cohort links ECLS renal support with survival and repair

Abstract

OBJECTIVES: To evaluate the association between renal replacement therapy (RRT) use and survival outcomes in infants with congenital diaphragmatic hernia (CDH) receiving extracorporeal life support (ECLS). DESIGN: Multicenter retrospective cohort study using the Extracorporeal Life Support Organization database (2011-2020). Propensity score (PS) matching was used to account for pre-ECLS disease severity. SETTING: International multicenter ECLS centers. PATIENTS: Infants with CDH requiring ECLS. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Of 2815 infants, 749 infants (26.6%) received RRT. Before matching, +RRT patients had significantly lower survival to discharge (35.5% vs. 60.2%; p < 0.0001). PS matching generated 413 pairs with balanced pre-ECLS characteristics. After matching, +RRT remained associated with significantly lower survival to discharge (36.3% vs. 57.4%; survival odds ratio, 0.42; 95% CI, 0.32-0.56; p < 0.0001). +RRT patients also experienced longer median ECLS durations (15 vs. 9.4 d; p < 0.0001) and higher rates of severe on-ECLS AKI (10.9% vs. 3.6%; p < 0.0001). Stratified analysis showed that RRT was associated with significantly worse survival only in patients undergoing on-ECLS CDH repair. CONCLUSIONS: In infants with CDH on ECLS, RRT use is strongly associated with increased ECLS duration and decreased survival to discharge. Although PS matching suggests this association persists regardless of baseline severity, RRT likely serves as a marker for significant clinical deterioration during the ECLS course.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.